FDA Advances Drug Development Innovation by Establishing ISTAND as Permanent Qualification Program

ISTAND supports innovative, science-driven approaches that improve drug development and regulatory decision-making, ultimately helping to make therapies available to address patients’ unmet needs.

administrator

Related Articles